Global Statistics

All countries
619,885,033
Confirmed
Updated on September 24, 2022 8:57 pm
All countries
598,260,969
Recovered
Updated on September 24, 2022 8:57 pm
All countries
6,539,503
Deaths
Updated on September 24, 2022 8:57 pm

Global Statistics

All countries
619,885,033
Confirmed
Updated on September 24, 2022 8:57 pm
All countries
598,260,969
Recovered
Updated on September 24, 2022 8:57 pm
All countries
6,539,503
Deaths
Updated on September 24, 2022 8:57 pm
- Advertisment -

How Many Covid Vaccines In Us

Covid Shot Is The Deadliest Vaccine Ever Created

Here’s how many Americans have been vaccinated for Covid-19 so far

It gets even worse though. In Pfizers childrens trial, one of the participants, 12-year-old Maddie De Garay, suffered a number of devastating events, including paralysis. This side effect was misreported, however, and put down as abdominal pain. Neither the FDA nor the CDC has investigated the case, despite promising to do so. Pfizer has refused to investigate it as well.

In the youth trial, 1 out of 1,131 children was paralyzed. Meanwhile, Pfizers adult trial shows that the shot saves one COVID death for every 22,000 fully-vaccinated people. But for children, its estimated we need to fully vaccinate over 630,000 kids to save one life. That means we may permanently disable as many as 557 kids per life saved. Meanwhile, theres not a single report of a healthy child dying from SARS-CoV-2 infection anywhere in the world.

This means the number needed to vaccinate to save one otherwise healthy child from COVID death is actually infinite, as theyre not dying from COVID to begin with. There simply is no doubt that in children, the COVID shot is no benefit and all risk. Kirsch notes:

Dr. Paul Offit was interviewed 20 years ago on CBS 60 Minutes, and he said the smallpox vaccine is so dangerous that we would never consider doing that in modern times. Its the most dangerous vaccine ever invented and the smallpox vaccines only kills one person per every million-people vaccinated, which is a lot.

India Offers Medical Supplies To African Nations In Fight Against Omicron Variant

From CNN’s Manveena Suri in New Delhi

India says it stands ready to support countries in Africa affected by the Omicron variant, including providing vaccines and medical supplies.

In a statement Monday, the Ministry of External Affairs said it was offering support to countries experiencing Omicron outbreaks by providing drugs, test kits, gloves, PPE kits and medical equipment such as ventilators.

The ministry also encouraged African nations to order India’s Covid-19 vaccines through COVAX, the World Health Organizations global vaccine sharing program, or bilaterally.

“We express our solidarity with the countries, particularly in Africa, who have so far been affected by the Omicron variant,” the MEA said.

“The Government of India stands ready to support the countries affected in Africa in dealing with the Omicron variant, including by supplies of Made-in-India vaccines.”

The MEA said the government has approved all orders placed so far by COVAX for supplies of Covishield, a vaccine developed by AstraZeneca-Oxford and produced by the Serum Institute of India, to African nations such as Malawi, Ethiopia, Zambia, Mozambique, Guinea and Lesotho.

Supplies of the India-made Covid-19 vaccine Covaxin have also been approved for Botswana.

Any new requirement projected either bilaterally or through COVAX will be considered expeditiously, according to the statement.

Should Children Get A Covid Vaccine

There has been a debate over the merits of vaccinating children who do not have underlying conditions as the chances of them developing a severe illness from COVID-19 are quite low, and this has to be balanced against the potential side effects of the vaccine.

The EMA acknowledged that the limited numbers in the studies involving children meant that they could not detect rare side effects. However, they concluded that the benefits of the vaccines for this younger age group outweighed any potential negatives.

There has also been some concern over cases of myocarditis and pericarditis following the administration of mRNA vaccines.

A Harvard article in July reported that there had been 1,000 cases after 300 million vaccinations in the US following either Pfizer or Moderna jabs. The majority of the cases were in teens or young adults.

The article also says that 79 per cent of these cases in young people were mild.

Despite vaccines having been approved for 12-18 year-olds by the European medicines regulator for the last two months, not all EU governments or health agencies have followed its lead.

However, many countries have started to open their vaccination programmes to children over the age of 12. This is how they compare.

Don’t Miss: How Much Is Covid Test At Cvs

Vaccine Development: Vaccines Approved For Use And In Clinical Trials

The speed at which the first COVID-19 vaccines were developed was extraordinary. We have previously looked into the history of vaccine development. The measles vaccine was found relatively rapidly: it took only 10 years from the discovery of the pathogen to the development of the first vaccine. But for typhoid it took more than a century, and for some diseases for which weve known the pathogens for more than a century we still havent found an effective vaccine.

The development of a vaccine against COVID-19 has been much faster than the development of any other vaccine. Within less than a year several successful vaccines have already been announced and were approved for use in some countries.

The hope is that even more manufacturers develop vaccines for COVID-19. This will be important because eventually a very large share of the world population needs to receive a COVID-19 vaccine.

We are on the way to several vaccines against COVID-19 vaccine trackers monitor the progress:

Several institutions maintain websites on which they list COVID-19 candidate vaccines that are currently being developed:

Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V

How The Us Vaccine Rollout Looks Right Now

Moderna expects European approval for COVID

Some seven months into the U.S. COVID-19 vaccine rollout, 51.9% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna drugs or a single injection of the one-dose Johnson & Johnson/Janssen version. Including “initial doses”those who have received only the first dose of Pfizer or Modernathe figure stands at 58.3%.

Now that the U.S. Food and Drug Administration has approved the Pfizer vaccine for 12- to 15-year-olds, the new pool of recipients may push national figures for new vaccine administrations back upward after a . The interactive maps and charts below are updated daily to track the progress of both the shipment of shots in the U.S. and the success in getting them into patients arms.

While a few smaller states say they have administered virtually all of the first doses they have received from the federal government, there remains a nationwide gap between the reported number of surplus doses and ground-level reports of mass shortages. While the Department of Health and Human Services releases weekly figures on vaccine allocations and shipments to every state, territory, and a handful of federal programs, these maps use Centers for Disease Control and Prevention figures to show how many of those doses have arrived on site each day.

Recommended Reading: How Much Are Cvs Covid Tests

Why Might Vaccines Need To Be Updated

Basically, its a question of whether a virus has changed enough so that antibodies created by the original vaccine are no longer able to recognize and fend off the new mutated variant.

Coronaviruses use spike proteins to attach to ACE-2 receptors on the surface of human cells and infect them. All mRNA COVID-19 vaccines work by giving instructions in the form of mRNA that direct cells to make a harmless version of the spike protein. This spike protein then induces the human body to produce antibodies. If a person is then ever exposed to the coronavirus, these antibodies bind to the coronaviruss spike protein and thus interfere with its ability to infect that persons cells.

The omicron variant contains a new pattern of mutations to its spike protein. These changes could disrupt the ability of some but probably not all of the antibodies induced by the current vaccines to bind to the spike protein. If that happens, the vaccines could be less effective at preventing people from getting infected by and transmitting the omicron variant.

Where Can I Get A Covid

All adults in the U.S. are eligible to receive a COVID-19 vaccine, and children 12 years and older are able to receive the Pfizer vaccine. Visit Vaccines.gov to find out where vaccines are in stock near you and schedule an appointment.

You can also text your ZIP code to 438 829 to receive contact information for vaccine providers in your area.

Illustrated guide: What to expect before and after getting a COVID-19 vaccine

Populations used for U.S. state, District of Columbia and Puerto Rico calculations are from the U.S. Census Bureau’s 2019 state population estimates. Populations used for other territory and associated island state calculations are from the World Bank.

The share of distributed doses used in each state or territory is calculated by dividing the number of doses administered in that state or territory by the number of doses distributed to that state or territory. The percent of people vaccinated in each state, territory or county is calculated by dividing the number of residents of that state, territory or county who have been vaccinated by the population of that state, territory or county.

Because of reporting delays and other factors, the CDC data above may differ from that of states’ and territories’ own reports and dashboards. For more information, see the footnotes on the CDC’s website. To see the CDC’s log of changes and corrections to the data, check the historical updates.

Contributing: Mitchell Thorson, Mike Stucka and Shawn Sullivan

You May Like: How Much Is Covid Test At Cvs

Biggest Fraud In History

All things considered, the COVID vaccination campaign is the biggest medical fraud in modern history. As Kirsch says, its a house of cards, held together by belief in data that arent there and avoidance of confronting the safety signals in the VAERS system and other studies that dont comport with the narrative.

They even avoided the determination of one of the worlds top pathologists that at least 30% to 40% of the deaths two weeks post-vaccine were caused by the vaccine. The still claim there are no deaths that have been attributed to the Pfizer or Moderna vaccines. Thats ridiculous.

Ive never seen anything like this, and Ive never heard of anything like this because the conspirators who are telling this false narrative are all the three-letter agencies under the Department of Health and Human Services the FDA, CDC and NIH.

Theyre all in on it, Congress is all in on it, mainstream medias all in on it, and the medical community is all in on it. They cant afford to back down now because they are in it too deep. It would be too embarrassing to them.

We have been saying for months, You guys have to look at the VAERS data, and they have been ignoring and censoring us rather than engaging us with dialogue and none of these people will engage us in dialogue.

What Share Of The Population Has Been Fully Vaccinated Against Covid

Covid-19 vaccines uncoupled infections and deaths says WHO Chief Scientist | Oneindia News

The following chart shows the share of the total population that has been fully vaccinated against COVID-19. This represents the share that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

You May Like: Covid Test Cost Cvs

What Vaccines Has Nigeria Received

Nigeria, among other African countries, struggled to access Covid vaccines earlier this year as wealthier nations, which had secured early deals, were given priority by manufacturers.

Many African states were also relying on the Covax scheme, which itself experienced difficulties earlier in the year meeting its commitments to supply vaccines, particularly across Africa.

But in recent weeks, delivery has improved as wealthier countries began releasing stocks they were holding, largely via the Covax system.

Nigeria received 700,000 doses of the AstraZeneca vaccine from the UK in August, and 800,000 from Canada in September, with a further 500,000 coming from France in October.

Around the same time, Nigeria also received four million doses of the Moderna vaccine and 3.6m Pfizer doses from the US.

Heres The Latest On What Courts Have Said About Bidens Vaccine Mandates

All three of President Bidens broad vaccine mandates affecting the private sector have been put on hold by courts.

The Biden administration issued three mandates in September one for federal contractors, another for healthcare workers, and a third for companies with more than 100 employees. Some Republican governors have argued that Mr. Biden does not have the authority to impose these mandates, which are estimated to cover more than 100 million workers.

And federal judges in Georgia, Louisiana and Missouri all appointed by Republicans have agreed in part, creating a roadblock for the administrations push to vaccinate all Americans. Before the court orders, local and private mandates had helped boost vaccination rates.

Heres where the court cases stand:

Also Check: How Much Is Rapid Test At Cvs

Status Of Leading Vaccines

This table documents the status of leading COVID-19 vaccines, showing authorizations for use in the US and other selected markets plus prices from information on purchase agreements compiled by UNICEF, where available.

The highly effective vaccines from Pfizer/BioNTech and Moderna are based on a new technology that delivers a sequence of RNA that makes our own cells produce viral protein, triggering an immune response.

The drawback is that these vaccines are more expensive than those made by splicing genetic material from the coronavirus into a disabled version of another virus. Examples of such vaccines include those produced by the Anglo-Swedish company AstraZeneca, based on research from Oxford University, Johnson & Johnson, and Russias Gamaleya Research Institute.

Other leading vaccines are based on inactivated versions of the coronavirus, a longstanding approach to making vaccines, or subunits of viral protein. One vaccine, from the Indian company Zydus Cadila, delivers a genetic sequence that makes a viral protein inside loops of DNA.

Jeremy Singer-Vine contributed reporting for this story.

Does An Updated Vaccine Need Full Clinical Trials

Covid

Its currently not clear how much clinical data would be required to get FDA approval or authorization for an updated COVID-19 vaccine. However, all the ingredients would be the same in a new vaccine. The only difference would be a few lines of genetic code that would ever so slightly change the shape of the spike protein. From a safety perspective, an updated vaccine is essentially identical to the already tested vaccines. Because of these similarities, clinical testing may not need to be as extensive as what was needed for the first-generation COVID-19 vaccines.

At a minimum, clinical trials for updated vaccines would likely require safety testing and confirmation that an updated vaccine induces antibody levels on par with the response of the original vaccine against the original, beta and delta strains. If these are the only requirements, then researchers would enroll only hundreds not tens of thousands of people to obtain the clinical data needed.

One important thing to note is that if vaccine manufacturers decide to update their vaccines for the omicron variant, it wouldnt be their first time making this kind of change.

If it turns out that omicron or any future variant, for that matter warrants a new vaccine, companies have already completed the dress rehearsals and are ready to meet the challenge.

This article was originally published on The Conversation. Read the original article.

Don’t Miss: When Is It Safe To Be Around Someone With Covid

How Two Groups Of The Unvaccinated Compare

The demographic profile of those who are waiting for more information about vaccines differs from those who say they will not consider them.

Note: The political party category includes independents who lean toward either party.

Ms. Drew and other people in the so-called wait-and-see group tend to be younger and harbor more concerns about the safety of the vaccines. They may be worried that the vaccines are too new, or about what friends have told them about side effects.

In one Kaiser survey, 44 percent said they would be more likely to get a vaccine once it is fully approved by the Food and Drug Administration. Currently, the three coronavirus vaccines being offered in the United States have only been granted an emergency use authorization, a step short of full approval.

Its gone from We arent getting it to OK, if I get more information Im going to get it.’ I would rather get it than to bury any one of my children or to have them bury me.

Lakeshia Drew, 41, who said she recently changed her mind about getting a vaccine.

Its kind of like the known versus the unknown for some of those people, said Mollyann Brodie, an executive vice president at the Kaiser Family Foundation, who runs the groups survey research. Fear is a hard thing to overcome, and there has been a lot of fearmongering with relation to the vaccine, and there is a lot of stuff that isnt known about it.

La Scala Welcomes Opera Lovers In Masks To Open Its Season

In the land of opera, there is no greater social event than the annual première at Milans Teatro alla Scala, Italys pre-eminent opera house. Every year, the Dec. 7 gala opening of the season draws glitterati, Milanese A-listers and freshly minted celebrities which these days includes the occasional virologist.

Other rank-and-file opera lovers have to settle for watching the event live on RAI 1, the national broadcasters flagship channel but on Monday evening, even that felt extraordinary. Italians considered the fact that Verdis Macbeth went ahead as scheduled and to a full house, no less as a welcome sign of normalcy, at a time when a new wave of coronavirus infections has forced theaters in other European countries to stay shut.

It wasnt exactly business as usual.

Masks were mandatory in the audience , and access to the theater was limited to people with a Super Green Pass, as Italys proof of vaccination or recovery from Covid-19 is known.

We did everything we had to do to ensure a safe environment, Dominique Meyer, the theaters top official, told reporters on Monday. Weve been very careful to protect the health of the theater workers as well as the spectators.

Noting the safety measures, Mr. Meyer said, If people behave seriously and with discipline, as they have until now, we can be optimistic.

These measures, along with other restrictions imposed last month, have made life increasingly difficult for the unvaccinated.

Also Check: Cost Of Rapid Test At Cvs

- Advertisment -

Hot Topics

- Advertisment -

Related Articles